| Literature DB >> 24520502 |
Batoul Tarokhian1, Roya Sherkat1, Mohamma Hossein Nasr Esfahani2, Minoo Adib3, Abbas Kiani Esfahani2, Behrooz Ataei4.
Abstract
BACKGROUND: Some evidence has shown a relationship between primary human cytomegalovirus (CMV) infection and pregnancy loss. The impact of CMV infection reactivation during pregnancy on adverse pregnancy outcomes is not completely understood. It is proposed that altered immune response, and therefore, recurrence or reactivation of latent CMV infection may relate to recurrent spontaneous abortion (RSA); however, few data are available in this regard. To find out about any cell mediated defect and reactivation of latent CMV infection in women with RPL, cellular immunity to the virus has been evaluated by specific cytotoxic T lymphocyte (CTL) response to CMV.Entities:
Keywords: CMV; Cytotoxic T Lymphocyte; Recurrent Abortion
Year: 2013 PMID: 24520502 PMCID: PMC3901180
Source DB: PubMed Journal: Int J Fertil Steril ISSN: 2008-0778
Fig 1Cytotoxic T-cell population using anti-CD3 (PerCP) and anti-CD8 (FITC). Each plot has been divided into four quadrants, each of which is representative of cells separated by related flourecent dye. a. CD3 single positive (PerCP), b. CD3/CD8 double positive (PerCP/FITC), c. CD8 single positive (FITC), d. double negative.
Fig 2Typical flow cytometry for CD107a expression on CD3+ CD8+ T cells.
Fig 3IFN-γ production in CD3+ CD8+ T cells.
Comparison of IFN-γ production in response to CMV PP65 and SEB antigen in CD3+ CD8+ T cells between control group and RSA patients
| Variant | Case | Control | P value | ||
|---|---|---|---|---|---|
| Mean (SD) | (Min-Max) | Mean (SD) | (Min-Max) | ||
| 0.64 ± 0.91 | 0.1-6.1 | 0.62 ± 0.70 | 0.1-3.5 | 0.89 | |
| 4.71 ± 0.43 | 3.4- 5.6 | 4.44 ± 1.07 | 0.1-5.8 | 0.22 | |
Results are expressed as percentage of IFN-γ positive cells.
Comparison of CD8 expression on surface of lymphocytes between RSA patients and control group
| Variant | RSA | Control | P value | ||
|---|---|---|---|---|---|
| Mean(SD) | (Min-Max) | Mean(SD) | (Min- Max) | ||
| 6.52 ± 4.12 | 1.78-20.22 | 5.39 ± 2.81 | 0.62-12.24 | 0.08 | |
Results are expressed as percentage of CD8 positive cells.
Comparison of anti-CMV IgG concentration between RSA patients and control group
| Variant | RSA | control | P value | ||
|---|---|---|---|---|---|
| Mean ± SD | (Min-Max) | Mean ± SD | (Min-Max) | ||
| 182.91 ± 74.89 | 73.03-291.67 | 190.19±70.54 | 75.03-282.02 | 0.32 | |
Correlation between anti-CMV IgG, CD107a, and IFN-γ in RSA and control group
| Variant | CD107a | Anti–CMV IgG | IFN-γ |
|---|---|---|---|
| r= -0.027P= 0.804 | r=-0.065P=0.563 | ||
| r= -0.027P= 0.804 | r =0.108P=0.333 | ||
| r=-0.065P=0.563 | r =0.108P=0.333 | ||
Comparison of CD107 expression in response to CMV PP65 and SEB antigen on CD3 + CD8+ T cells between control group and RSA patients
| Variant | RSA | Control | p-value | ||
|---|---|---|---|---|---|
| Mean(SD) | (Min, Max) | Mean(SD) | (Min, Max) | ||
| 2.63 ± 1.18 | 0.6, 5.5 | 2.78 ± 1.43 | 0.8, 7.2 | 0.29 | |
| 11.17 ± 6.09 | 0.1, 23 | 13.73 ± 4.95 | 5.30, 22 | 0.042* | |
Results are expressed as percentage of CD107a positive cells. *; The value of p<0.05 was considered significant.